Next Article in Journal
Design and Mechanism of Action of a New Prototype of Combi-Molecule “Programed” to Release Bioactive Species at a pH Range Akin to That of the Tumor Microenvironment
Next Article in Special Issue
The Case for GNMT as a Biomarker and a Therapeutic Target in Pancreatic Cancer
Previous Article in Journal
Preparation and Bioevaluation of Novel 99mTc-Labeled Complexes with a 2-Nitroimidazole HYNIC Derivative for Imaging Tumor Hypoxia
Previous Article in Special Issue
Cytostatic Action of Novel Histone Deacetylase Inhibitors in Androgen Receptor-Null Prostate Cancer Cells
 
 
Case Report

Article Versions Notes

Pharmaceuticals 2021, 14(2), 159; https://doi.org/10.3390/ph14020159
Action Date Notes Link
article pdf uploaded. 16 February 2021 11:28 CET Version of Record https://www.mdpi.com/1424-8247/14/2/159/pdf-vor
article xml file uploaded 25 February 2021 16:58 CET Original file -
article xml uploaded. 25 February 2021 16:58 CET Update https://www.mdpi.com/1424-8247/14/2/159/xml
article pdf uploaded. 25 February 2021 16:58 CET Updated version of record https://www.mdpi.com/1424-8247/14/2/159/pdf
article html file updated 25 February 2021 16:59 CET Original file -
article html file updated 25 July 2022 03:42 CEST Update https://www.mdpi.com/1424-8247/14/2/159/html
Back to TopTop